Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial
James F Markmann, Marwan S Abouljoud, R Mark Ghobrial, Chandra S Bhati, Shawn J Pelletier, Amy D Lu, Shane Ottmann, Tarunjeet Klair, Corey Eymard, Garrett R Roll, Joseph Magliocca, Timothy L Pruett, Jorge Reyes, Sylvester M Black, Christopher L Marsh, Gabriel Schnickel, Milan Kinkhabwala, Sander S Florman, Shaheed Merani, Anthony J Demetris, Shoko Kimura, Michael Rizzari, Ashish Saharia, Marlon Levy, Avinash Agarwal, Francisco G Cigarroa, James D Eason, Shareef Syed, W Kenneth Washburn, Justin Parekh, Jang Moon, Alexander Maskin, Heidi Yeh, Parsia A Vagefi, Malcolm P MacConmara, James F Markmann, Marwan S Abouljoud, R Mark Ghobrial, Chandra S Bhati, Shawn J Pelletier, Amy D Lu, Shane Ottmann, Tarunjeet Klair, Corey Eymard, Garrett R Roll, Joseph Magliocca, Timothy L Pruett, Jorge Reyes, Sylvester M Black, Christopher L Marsh, Gabriel Schnickel, Milan Kinkhabwala, Sander S Florman, Shaheed Merani, Anthony J Demetris, Shoko Kimura, Michael Rizzari, Ashish Saharia, Marlon Levy, Avinash Agarwal, Francisco G Cigarroa, James D Eason, Shareef Syed, W Kenneth Washburn, Justin Parekh, Jang Moon, Alexander Maskin, Heidi Yeh, Parsia A Vagefi, Malcolm P MacConmara
Abstract
Importance: Ischemic cold storage (ICS) of livers for transplant is associated with serious posttransplant complications and underuse of liver allografts.
Objective: To determine whether portable normothermic machine perfusion preservation of livers obtained from deceased donors using the Organ Care System (OCS) Liver ameliorates early allograft dysfunction (EAD) and ischemic biliary complications (IBCs).
Design, setting, and participants: This multicenter randomized clinical trial (International Randomized Trial to Evaluate the Effectiveness of the Portable Organ Care System Liver for Preserving and Assessing Donor Livers for Transplantation) was conducted between November 2016 and October 2019 at 20 US liver transplant programs. The trial compared outcomes for 300 recipients of livers preserved using either OCS (n = 153) or ICS (n = 147). Participants were actively listed for liver transplant on the United Network of Organ Sharing national waiting list.
Interventions: Transplants were performed for recipients randomly assigned to receive donor livers preserved by either conventional ICS or the OCS Liver initiated at the donor hospital.
Main outcomes and measures: The primary effectiveness end point was incidence of EAD. Secondary end points included OCS Liver ex vivo assessment capability of donor allografts, extent of reperfusion syndrome, incidence of IBC at 6 and 12 months, and overall recipient survival after transplant. The primary safety end point was the number of liver graft-related severe adverse events within 30 days after transplant.
Results: Of 293 patients in the per-protocol population, the primary analysis population for effectiveness, 151 were in the OCS Liver group (mean [SD] age, 57.1 [10.3] years; 102 [67%] men), and 142 were in the ICS group (mean SD age, 58.6 [10.0] years; 100 [68%] men). The primary effectiveness end point was met by a significant decrease in EAD (27 of 150 [18%] vs 44 of 141 [31%]; P = .01). The OCS Liver preserved livers had significant reduction in histopathologic evidence of ischemia-reperfusion injury after reperfusion (eg, less moderate to severe lobular inflammation: 9 of 150 [6%] for OCS Liver vs 18 of 141 [13%] for ICS; P = .004). The OCS Liver resulted in significantly higher use of livers from donors after cardiac death (28 of 55 [51%] for the OCS Liver vs 13 of 51 [26%] for ICS; P = .007). The OCS Liver was also associated with significant reduction in incidence of IBC 6 months (1.3% vs 8.5%; P = .02) and 12 months (2.6% vs 9.9%; P = .02) after transplant.
Conclusions and relevance: This multicenter randomized clinical trial provides the first indication, to our knowledge, that normothermic machine perfusion preservation of deceased donor livers reduces both posttransplant EAD and IBC. Use of the OCS Liver also resulted in increased use of livers from donors after cardiac death. Together these findings indicate that OCS Liver preservation is associated with superior posttransplant outcomes and increased donor liver use.
Trial registration: ClinicalTrials.gov Identifier: NCT02522871.
Conflict of interest statement
Conflict of Interest Disclosures: Dr Bhati reported receiving personal fees from Intuitive Surgical outside the submitted work. Dr Pelletier reported receiving funding from Organ Recovery Systems outside the submitted work. Dr Lu reported receiving nonfinancial support from Tampa General Hospital during the conduct of the study. Dr Saharia reported receiving nonfinancial support from Houston Methodist Hospital during the conduct of the study. Dr Cigarroa reported receiving financial compensation from the Ford Foundation, Capital Group, Kleberg Foundation, and Clayton Foundation for Biomedical Research outside the submitted work. Dr MacConmara reported becoming employed by TransMedics after completion of the OCS Liver PROTECT randomized clinical trial and submission of the final manuscript. No other disclosures were reported.
Figures
References
- Kwong A, Kim WR, Lake JR, et al. . OPTN/SRTR 2018 annual data report: liver. Am J Transplant. 2020;20(suppl s1):193-299. doi:10.1111/ajt.15674
- Klassen DK, Edwards LB, Stewart DE, Glazier AK, Orlowski JP, Berg CL. The OPTN deceased donor potential study: implications for policy and practice. Am J Transplant. 2016;16(6):1707-1714. doi:10.1111/ajt.13731
- Feng S. Donor intervention and organ preservation: where is the science and what are the obstacles? Am J Transplant. 2010;10(5):1155-1162. doi:10.1111/j.1600-6143.2010.03100.x
- Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation. 2007;83(10):1289-1298. doi:10.1097/
- Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts: an overview and synthesis of current studies. Transplantation. 1992;53(5):957-978. doi:10.1097/00007890-199205000-00001
- Feng S, Goodrich NP, Bragg-Gresham JL, et al. . Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783-790. doi:10.1111/j.1600-6143.2006.01242.x
- Trapero-Marugán M, Little EC, Berenguer M. Stretching the boundaries for liver transplant in the 21st century. Lancet Gastroenterol Hepatol. 2018;3(11):803-811. doi:10.1016/S2468-1253(18)30213-9
- Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW. Ischaemia-reperfusion injury in liver transplantation—from bench to bedside. Nat Rev Gastroenterol Hepatol. 2013;10(2):79-89. doi:10.1038/nrgastro.2012.225
- Steinbrook R. Organ donation after cardiac death. N Engl J Med. 2007;357(3):209-213. doi:10.1056/NEJMp078066
- Olthoff KM, Kulik L, Samstein B, et al. . Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943-949. doi:10.1002/lt.22091
- Schön MR, Kollmar O, Wolf S, et al. . Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg. 2001;233(1):114-123. doi:10.1097/00000658-200101000-00017
- St Peter SD, Imber CJ, Friend PJ. Liver and kidney preservation by perfusion. Lancet. 2002;359(9306):604-613. doi:10.1016/S0140-6736(02)07749-8
- Butler AJ, Rees MA, Wight DG, et al. . Successful extracorporeal porcine liver perfusion for 72 hr. Transplantation. 2002;73(8):1212-1218. doi:10.1097/00007890-200204270-00005
- Liu Q, Nassar A, Farias K, et al. . Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl. 2014;20(8):987-999. doi:10.1002/lt.23906
- Nassar A, Liu Q, Farias K, et al. . Ex vivo normothermic machine perfusion is safe, simple, and reliable: results from a large animal model. Surg Innov. 2015;22(1):61-69. doi:10.1177/1553350614528383
- Nasralla D, Coussios CC, Mergental H, et al. ; Consortium for Organ Preservation in Europe . A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557(7703):50-56. doi:10.1038/s41586-018-0047-9
- Ali JM, Davies SE, Brais RJ, et al. . Analysis of ischemia/reperfusion injury in time-zero biopsies predicts liver allograft outcomes. Liver Transpl. 2015;21(4):487-499. doi:10.1002/lt.24072
- Kakizoe S, Yanaga K, Starzl TE, Demetris AJ. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology. 1990;11(6):932-941. doi:10.1002/hep.1840110605
- Sosa RA, Zarrinpar A, Rossetti M, et al. . Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation. JCI Insight. 2016;1(20):e89679. doi:10.1172/jci.insight.89679
- Sayed E, Selman E, El Khola A, Khalil M, Lofty M. Intraoperative serum lactate concentration and central venous oxygen saturation as early predictors for early graft function during liver transplant. J Anest Inten Care Med. 2018;5(1):555655. doi:10.19080/JAICM.2018.05.555655
- Ardehali A, Esmailian F, Deng M, et al. ; PROCEED II trial investigators . Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;385(9987):2577-2584. doi:10.1016/S0140-6736(15)60261-6
- He X, Guo Z, Zhao Q, et al. . The first case of ischemia-free organ transplantation in humans: a proof of concept. Am J Transplant. 2018;18(3):737-744. doi:10.1111/ajt.14583
- He X, Chen G, Zhu Z, et al. . The first case of ischemia-free kidney transplantation in humans. Front Med (Lausanne). 2019;6:276. doi:10.3389/fmed.2019.00276
- Warnecke G, Moradiellos J, Tudorache I, et al. . Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet. 2012;380(9856):1851-1858. doi:10.1016/S0140-6736(12)61344-0
- Warnecke G, Van Raemdonck D, Smith MA, et al. . Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. [published correction appears in Lancet Respir Med. 2018;6(6):e27]. Lancet Respir Med. 2018;6(5):357-367. doi:10.1016/S2213-2600(18)30136-X
- Loor G, Warnecke G, Villavicencio MA, et al. . Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. Lancet Respir Med. 2019;7(11):975-984. doi:10.1016/S2213-2600(19)30200-0
- Fondevila C, Hessheimer AJ, Maathuis MH, et al. . Superior preservation of DCD livers with continuous normothermic perfusion. Ann Surg. 2011;254(6):1000-1007. doi:10.1097/SLA.0b013e31822b8b2f
- Dutkowski P, Polak WG, Muiesan P, et al. . First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: an international-matched case analysis. Ann Surg. 2015;262(5):764-770. doi:10.1097/SLA.0000000000001473
- Oniscu GC, Randle LV, Muiesan P, et al. . In situ normothermic regional perfusion for controlled donation after circulatory death—the United Kingdom experience. Am J Transplant. 2014;14(12):2846-2854. doi:10.1111/ajt.12927
- Mergental H, Laing RW, Kirkham AJ, et al. . Transplantation of discarded livers following viability testing with normothermic machine perfusion. Nat Commun. 2020;11(1):2939. doi:10.1038/s41467-020-16251-3
- van Rijn R, Schurink IJ, de Vries Y, et al. ; DHOPE-DCD Trial Investigators . Hypothermic machine perfusion in liver transplantation—a randomized trial. N Engl J Med. 2021;384(15):1391-1401. doi:10.1056/NEJMoa2031532
- Williams WW, Markmann JF. Warming up to cold perfusion. N Engl J Med. 2021;384(15):1458-1459. doi:10.1056/NEJMe2102056
- Snyder JJ, Salkowski N, Wey A, Pyke J, Israni AK, Kasiske BL. Organ distribution without geographic boundaries: a possible framework for organ allocation. Am J Transplant. 2018;18(11):2635-2640. doi:10.1111/ajt.15115
Source: PubMed